Xtx Topco LTD Zentalis Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 122,988 shares of ZNTL stock, worth $274,263. This represents 0.03% of its overall portfolio holdings.
Number of Shares
122,988
Previous 194,062
36.62%
Holding current value
$274,263
Previous $712,000
47.75%
% of portfolio
0.03%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding ZNTL
# of Institutions
147Shares Held
65.3MCall Options Held
43.2KPut Options Held
21.7K-
Matrix Capital Management Company, LP Waltham, MA14MShares$31.1 Million2.05% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$10.7 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.48MShares$9.98 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$7.29 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.22MShares$7.17 Million0.0% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $127M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...